{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:51:49Z","timestamp":1783525909082,"version":"3.55.0"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GKR1949"],"award-info":[{"award-number":["GKR1949"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2098"],"award-info":[{"award-number":["GRK2098"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01386","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T13:20:26Z","timestamp":1560950426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Intestinal Acid Sphingomyelinase Protects From Severe Pathogen-Driven Colitis"],"prefix":"10.3389","volume":"10","author":[{"given":"Jana","family":"Meiners","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Klopfleisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana-Fabienne","family":"Ebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Japtok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan Mohamud","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Z\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Kleuser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Kolesnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Buer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid M.","family":"Westendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi","year":"1998","journal-title":"Gastroenterology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1007\/s00018-017-2518-9","article-title":"Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity","volume":"74","author":"Oertel","year":"2017","journal-title":"Cell Mol Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.3748\/wjg.v13.i39.5217","article-title":"Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function","volume":"13","author":"Bock","year":"2007","journal-title":"World J Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1096\/fj.08-118109","article-title":"A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis","volume":"23","author":"Snider","year":"2009","journal-title":"FASEB J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ccr.2012.11.013","article-title":"Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer","volume":"23","author":"Liang","year":"2013","journal-title":"Cancer Cell."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1096\/fj.201600394R","article-title":"Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans","volume":"30","author":"Huang","year":"2016","journal-title":"FASEB J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3389\/fphys.2014.00331","article-title":"Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons","volume":"5","author":"Beckmann","year":"2014","journal-title":"Front Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-2567.2007.02612.x","article-title":"Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice","volume":"122","author":"Sakata","year":"2007","journal-title":"Immunology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.prostaglandins.2018.12.002","article-title":"Inhibition of ASM activity ameliorates DSS-induced colitis in mice","volume":"140","author":"Xiong","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2963","DOI":"10.1038\/cddis.2017.360","article-title":"Acid sphingomyelinase mediates human CD4(+) T-cell signaling: potential roles in T-cell responses and diseases","volume":"8","author":"Bai","year":"2017","journal-title":"Cell Death Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4292\/wjgpt.v3.i6.83","article-title":"Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-kappaB\/nitric oxide pathway and inhibition of cytokine production: a hypothesis","volume":"3","author":"Rahimi","year":"2012","journal-title":"World J Gastrointest Pharmacol Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/gut.48.1.132","article-title":"Bacteria as the cause of ulcerative colitis","volume":"48","author":"Campieri","year":"2001","journal-title":"Gut."},{"key":"B17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/2040622313485275","article-title":"Prevention of infection caused by immunosuppressive drugs in gastroenterology","volume":"4","author":"Orlicka","year":"2013","journal-title":"Ther Adv Chronic Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/ng0795-288","article-title":"Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease","volume":"10","author":"Horinouchi","year":"1995","journal-title":"Nat Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1158\/0008-5472.CAN-13-3065","article-title":"Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer","volume":"74","author":"Pastille","year":"2014","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1159\/000430295","article-title":"IL10-Deficiency in CD4(+) T cells exacerbates the IFN\u03b3 and IL17 response during bacteria induced colitis","volume":"36","author":"Seiffart","year":"2015","journal-title":"Cell Physiol Biochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.plipres.2008.04.003","article-title":"Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development","volume":"48","author":"Duan","year":"2009","journal-title":"Prog Lipid Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000315101","article-title":"Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications","volume":"26","author":"Kornhuber","year":"2010","journal-title":"Cell Physiol Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-7091-1368-4_9","article-title":"Functional inhibitors of acid sphingomyelinase (FIASMAs)","author":"Kornhuber","year":"2013","journal-title":"Handb Exp Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrmicro3315","article-title":"Citrobacter rodentium: infection, inflammation and the microbiota","volume":"12","author":"Collins","year":"2014","journal-title":"Nat Rev Microbiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1084\/jem.20130903","article-title":"Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium","volume":"210","author":"Schreiber","year":"2013","journal-title":"J Exp Med."},{"key":"B26","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/IAI.67.6.3031-3039.1999","article-title":"Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease","volume":"67","author":"Higgins","year":"1999","journal-title":"Infect Immun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4049\/jimmunol.172.1.433","article-title":"Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen","volume":"172","author":"Bry","year":"2004","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1128\/IAI.74.1.673-681.2006","article-title":"CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium","volume":"74","author":"Bry","year":"2006","journal-title":"Infect Immun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.4049\/jimmunol.168.4.1804","article-title":"Impaired resistance and enhanced pathology during infection with a noninvasive, attaching-effacing enteric bacterial pathogen, Citrobacter rodentium, in mice lacking IL-12 or IFN-gamma","volume":"168","author":"Simmons","year":"2002","journal-title":"J Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/j.1462-5822.2005.00625.x","article-title":"Citrobacter rodentium of mice and man","volume":"7","author":"Mundy","year":"2005","journal-title":"Cell Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature04754","article-title":"Transforming growth factor-beta induces development of the T(H)17 lineage","volume":"441","author":"Mangan","year":"2006","journal-title":"Nature."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/mi.2014.17","article-title":"Regulatory T cells promote a protective Th17-associated immune response to intestinal bacterial infection with C. rodentium","volume":"7","author":"Wang","year":"2014","journal-title":"Mucosal Immunol."},{"key":"B33","volume-title":"Amitriptyline Hydrochloride: An Antidepressive Agent: R\u00e9sum\u00e9 of Essential Information","author":"Merck Sharp","year":"1961"},{"key":"B34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/art.1780290510","article-title":"Evaluation of amitriptyline in primary fibrositis","volume":"29","author":"Carette","year":"1986","journal-title":"A double-blind, placebo-controlled study. Arthritis Rheum."},{"key":"B35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1212\/WNL.26.2.121","article-title":"Amitriptyline in the prophylaxis of migraine","volume":"26","author":"Couch","year":"1976","journal-title":"Effectiveness and relationship of antimigraine and antidepressant effects. Neurology."},{"key":"B36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/j.1875-9114.1990.tb02582.x","article-title":"Antidepressants in the management of chronic pain syndromes","volume":"10","author":"Egbunike","year":"1990","journal-title":"Pharmacotherapy."},{"key":"B37","first-page":"279","article-title":"Therapeutic trial of amitryptiline in the treatment of nocturnal enuresis\u2013a controlled study","volume":"17","author":"Mishra","year":"1980","journal-title":"Indian Pediatr."},{"key":"B38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0889-8553(21)00554-9","article-title":"Treatment of the irritable bowel syndrome","volume":"20","author":"Friedman","year":"1991","journal-title":"Gastroenterol Clin North Am."},{"key":"B39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1590\/S1517-83822010000300014","article-title":"An investigation on in vitro and in vivo antimicrobial properties of the antidepressant: amitriptyline hydrochloride","volume":"41","author":"Mandal","year":"2010","journal-title":"Braz J Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1465-9921-8-35","article-title":"Anti-inflammatory properties of desipramine and fluoxetine","volume":"8","author":"Roumestan","year":"2007","journal-title":"Respir Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/imr.12039","article-title":"CD4(+) T-cell subsets in intestinal inflammation","volume":"252","author":"Shale","year":"2013","journal-title":"Immunol Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4161\/self.1.4.13560","article-title":"Immunopathogenesis of inflammatory bowel disease","volume":"1","author":"Matricon","year":"2010","journal-title":"Self Nonself."},{"key":"B43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMoa1513248","article-title":"Ozanimod induction and maintenance treatment for ulcerative colitis","volume":"374","author":"Sandborn","year":"2016","journal-title":"N Engl J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/toxsci\/kfh006","article-title":"The mycotoxin fumonisin B1 alters the proliferation and the barrier function of porcine intestinal epithelial cells","volume":"77","author":"Bouhet","year":"2004","journal-title":"Toxicol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1128\/IAI.71.2.872-881.2003","article-title":"Disruption of epithelial barrier integrity by Salmonella enterica serovar typhimurium requires geranylgeranylated proteins","volume":"71","author":"Tafazoli","year":"2003","journal-title":"Infect Immun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"9890141","DOI":"10.1155\/2016\/9890141","article-title":"Sphingolipids as mediators in the crosstalk between microbiota and intestinal cells: implications for inflammatory bowel disease","volume":"2016","author":"Bryan","year":"2016","journal-title":"Mediat Inflamm."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.rmed.2012.06.014","article-title":"Different features of lung involvement in Niemann-Pick disease and Gaucher disease","volume":"106","author":"Gulhan","year":"2012","journal-title":"Respir Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.22037\/ijpr.2016.1813","article-title":"Anti-inflammatory effect of amitriptyline on ulcerative colitis in normal and reserpine-induced depressed rats","volume":"15","author":"Fattahian","year":"2016","journal-title":"Iran J Pharm Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1053\/j.gastro.2006.02.004","article-title":"Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease","volume":"130","author":"Garcia Rodriguez","year":"2006","journal-title":"Gastroenterology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/00001574-199607000-00003","article-title":"Microbial factors in chronic intestinal inflammation","volume":"12","author":"Sartor","year":"1996","journal-title":"Curr Opin Gastroenterol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/S0140-6736(11)61752-2","article-title":"Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa","volume":"379","author":"Feasey","year":"2012","journal-title":"Lancet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e0005697","DOI":"10.1371\/journal.pntd.0005697","article-title":"Virulence of invasive Salmonella Typhimurium ST313 in animal models of infection","volume":"11","author":"Ramachandran","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1084\/jem.20050246","article-title":"Repression of SPI2 transcription by nitric oxide-producing, IFNgamma-activated macrophages promotes maturation of Salmonella phagosomes","volume":"202","author":"McCollister","year":"2005","journal-title":"J Exp Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"5346","DOI":"10.1128\/IAI.00689-07","article-title":"Constitutive acid sphingomyelinase enhances early and late macrophage killing of Salmonella enterica serovar Typhimurium","volume":"75","author":"McCollister","year":"2007","journal-title":"Infect Immun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.4049\/jimmunol.170.5.2621","article-title":"Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase","volume":"170","author":"Utermohlen","year":"2003","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1128\/IAI.00093-07","article-title":"Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen","volume":"76","author":"Bergstrom","year":"2008","journal-title":"Infect Immun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41419-017-0214-1","article-title":"Sphingolipid de novo biosynthesis is essential for intestine cell survival and barrier function","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1365-2249.2009.03934.x","article-title":"Involvement of T helper type 17 and regulatory T cell activity in Citrobacter rodentium invasion and inflammatory damage","volume":"157","author":"Symonds","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2008.11.009","article-title":"Differential roles of interleukin-17A and\u221217F in host defense against mucoepithelial bacterial infection and allergic responses","volume":"30","author":"Ishigame","year":"2009","journal-title":"Immunity."},{"key":"B61","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.imbio.2011.10.021","article-title":"C6-ceramide enhances Interleukin-12-mediated T helper type 1 cell responses through a cyclooxygenase-2-dependent pathway","volume":"217","author":"Kue","year":"2012","journal-title":"Immunobiology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1828","DOI":"10.1038\/cddis.2015.178","article-title":"Role of acid sphingomyelinase bioactivity in human CD4+ T-cell activation and immune responses","volume":"6","author":"Bai","year":"2015","journal-title":"Cell Death Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.4049\/jimmunol.1400346","article-title":"CD39 and CD161 modulate Th17 responses in Crohn's disease","volume":"193","author":"Bai","year":"2014","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1159\/000447806","article-title":"Acid Sphingomyelinase (ASM) is a negative regulator of regulatory T Cell (Treg) development","volume":"39","author":"Zhou","year":"2016","journal-title":"Cell Physiol Biochem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1515\/hsz-2018-0159","article-title":"CD4+ Foxp3+ regulatory T cell-mediated immunomodulation by anti-depressants inhibiting acid sphingomyelinase","volume":"399","author":"Schneider-Schaulies","year":"2018","journal-title":"Biol Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00109-014-1246-y","article-title":"Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis","volume":"93","author":"Peng","year":"2015","journal-title":"J Mol Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/SHK.0000000000000648","article-title":"Amitriptyline usage exacerbates the immune suppression following burn injury","volume":"46","author":"Johnson","year":"2016","journal-title":"Shock (Augusta Ga.)."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.4049\/jimmunol.1600691","article-title":"Inhibition of acid sphingomyelinase allows for selective targeting of CD4+ conventional versus Foxp3+ regulatory T cells","volume":"197","author":"Hollmann","year":"2016","journal-title":"J Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01386\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T23:19:40Z","timestamp":1721431180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01386\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":68,"alternative-id":["10.3389\/fimmu.2019.01386"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01386","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"article-number":"1386"}}